Human Plasma-Derived Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
84
NCT04148118
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Phase: Phase 1
Role: Collaborator
Start: Jan 8, 2020
Completion: Sep 2, 2021
Loading map...